Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today.
Sales increased 2% year-over-year to $13.8 billion.
GAAP net income fell 17% to $3 billion, or $1.18 per share, last year. Adjusted EPS dropped 7% to $1.62.
For FY2023, Merck expects revenue of $57.2-58.7 billion and adjusted EPS of $6.80-6.95.
Prior performance
![Merck Q3 2022 earnings infographic](https://cdn.news.alphastreet.com/wp-content/uploads/2022/10/Merck-Q3-2022-earnings-infographic-608x1024.jpg)